NPRA approves six-month shelf life extension for Coronavac, Comirnaty Covid-19 vaccines

PUTRAJAYA: The National Pharmaceutical Regulatory Agency (NPRA) has approved an extension for the shelf life of SinoVac's CoronaVac and Pfizer-BioNTech's Comirnaty Covid-19 vaccines, says Health director-general Tan Sri Dr Noor Hisham Abdullah.

He said NPRA had approved the respective applications from Pharmaniaga Lifescience Sdn Bhd and Pfizer (Malaysia) Sdn Bhd.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Expiry date , Shelf life , SinoVac , CoronaVac , Pfizer , BioNTech , Comirnaty , Covid-19 , Vaccine , Health Ministry , Noor Hisham Abdullah

Next In Nation
MACC denies Rafizi's allegations it was used to probe PKR polls candidates
Man killed as piling machine falls on his 4WD vehicle in Lawas
Police personnel stationed on rotational basis at KL Court Complex to curb touting
Police investigate Gombak domestic helper abuse claim
Chemor residents living in fear after tiger attacks on cattle
Sg Petani cops detain man who threatened neighbour with gun
Jaywalker hit by motorbike while chatting with lorry driver on JB road
Thirty motorcycles seized during anti-street racing crackdown in Ipoh
Developers urged to reduce parking spaces for new projects near public transport stations
Immigration detains 139 foreigners in KL anti-vice raids

Trending in News

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.